Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II. (Q40928849)

24 September 2017

title

Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II. (English)

1 reference

24 September 2017

1 reference

Liaw PC

1

1 reference

24 September 2017

Austin RC

2

1 reference

24 September 2017

Fredenburgh JC

3

1 reference

24 September 2017

Stafford AR

4

1 reference

24 September 2017

Weitz JI

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

Journal of Biological Chemistry

24 September 2017

published in

1 reference

24 September 2017

volume

274

1 reference

24 September 2017

issue

39

1 reference

24 September 2017

page(s)

27597-27604

1 reference

Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Characterization of specific receptors for vasopressin in the pituitary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Regulation of thrombin activity by antithrombin and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Oligonucleotide inhibitors of human thrombin that bind distinct epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Refined structure of the hirudin-thrombin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Inhibition of chymotrypsin by heparin cofactor II

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor II

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Structural evidence for leucine at the reactive site of heparin cofactor II

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor II

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Effects of low-molecular-weight dermatan sulfate on coagulation, fibrinolysis and tissue factor pathway inhibitor in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Vasoflux, a new anticoagulant with a novel mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Evidence for Allosteric Linkage between Exosites 1 and 2 of Thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

Heparin facilitates dissociation of complexes between thrombin and a reactive site mutant (L444R) of heparin cofactor II

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.274.39.27597

21 January 2018

Identifiers

DOI

10.1074/JBC.274.39.27597

1 reference

24 September 2017

1 reference